Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
AstraZeneca
Express Scripts
Colorcon
Mallinckrodt

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Benzimidazole

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Benzimidazole: Sponsors, patents, clinical trial progress

Benzimidazole is an investigational drug.

There have been 12 clinical trials for Benzimidazole. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2013.

The most common disease conditions in clinical trials are Helminthiasis, Neoplasms, Plasma Cell, and Anemia, Hemolytic. The leading clinical trial sponsors are Sidney Kimmel Comprehensive Cancer Center, University Ghent, and University of Washington.

There are three US patents protecting this investigational drug and forty-three international patents.

Recent Clinical Trials for Benzimidazole
TitleSponsorPhase
Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric PatientsAlejandro KrolewieckiPhase 2
Validating Egg-based Diagnostics and Molecular Markers for the Spread of Anthelmintic ResistanceSwiss Tropical & Public Health InstituteN/A
Validating Egg-based Diagnostics and Molecular Markers for the Spread of Anthelmintic ResistanceUniversity GhentN/A

See all Benzimidazole clinical trials

Clinical Trial Summary for Benzimidazole

Top disease conditions for Benzimidazole
Top clinical trial sponsors for Benzimidazole

See all Benzimidazole clinical trials

US Patents for Benzimidazole

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Benzimidazole   See Pricing Materials for organic light emitting diode UNIVERSAL DISPLAY CORPORATION (Ewing, NJ)   See Pricing
Benzimidazole   See Pricing Small molecule HSP70 inhibitors The Trustees of the University of Pennsylvania (Philadelphia, PA) The Wistar Institute of Anatomy and Biology (Philadelphia, PA)   See Pricing
Benzimidazole   See Pricing Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the treatment of inter alia diabetes APOGLYX AB (Lund, SE)   See Pricing
Benzimidazole   See Pricing Pyrene derivative, organic light-emitting medium, and organic electroluminescent element containing pyrene derivative or organic light-emitting medium IDEMITSU KOSAN CO., LTD. (Tokyo, JP)   See Pricing
Benzimidazole   See Pricing Aromatic amine derivative, and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. (Chiyoda-ku, JP)   See Pricing
Benzimidazole   See Pricing Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators HMI Medical Innovations, LLC (Southfield, MI)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Benzimidazole

Drugname Country Document Number Estimated Expiration Related US Patent
Benzimidazole China 101657518 2027-03-08   See Pricing
Benzimidazole China 102911213 2027-03-08   See Pricing
Benzimidazole China 103087109 2027-03-08   See Pricing
Benzimidazole China 105153235 2027-03-08   See Pricing
Benzimidazole China 108467414 2027-03-08   See Pricing
Benzimidazole European Patent Office 2121871 2027-03-08   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Colorcon
Merck
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.